- Joined
- Nov 20, 2018
- Messages
- 287
- Reaction score
- 197
APhA is reinforcing the importance of H.R. 7213, which would allow limited but significant Medicare reimbursement for pharmacists, after the American Medical Association (AMA) tried to undermine the bill. AMA laid out a case against the proposal in a letter to key lawmakers on April 12, but APhA says the medical society painted an inaccurate picture of the legislation and presented a view not reflected by the majority of doctors who work with pharmacists. Rather than collaborate on meaningful and impactful health care reform, APhA suggests AMA is on a self-serving mission to preserve a competitive edge for its membership. The Equitable Community Access to Pharmacists Services Act has been a long time coming, it says, and the role of pharmacists in vaccinating underserved populations and alleviating the burden on physicians during the COVID-19 outbreak only clarified its need. "Now, more than ever," APhA emphasizes in a new statement, "it is time to recognize pharmacists for all they have done, and all they can do, to keep our country safe, and help us avoid or manage the next pandemic — not block these health care professionals from serving to the full extent of their training, practice, and license." (Read More) |
Received this notice from APhA. You can click through to read the full response and AMA's stated opposition to proposed expanded RPh practice rights.